Contact the Editorial Desk

Editorial correspondence

Rejuvenation Peptide welcomes correspondence on the research record: a citation that has been quoted inaccurately, a regulatory reference that has gone out of date, or a peer-reviewed study about GHK-Cu or the GLOW blend (or its BPC-157 or TB-500 components) that should be added to the references page. Corrections that sharpen the accuracy of the numbers are the most useful messages received and are read carefully.

The most actionable notes specify three things: the page they refer to, the exact passage or number in question, and the supporting citation — a DOI or PubMed ID wherever possible. That lets a proposed change be verified against the primary source before anything is updated.

Editorial mailbox: editors@rejuvenationpeptide.com

What this desk cannot do

A few things fall outside what this site can address, so that no message goes unanswered for the wrong reason. Rejuvenation Peptide is a literature digest, not a clinic or a vendor, so we cannot:

• Advise on, recommend, or comment on human use of any peptide discussed here, whether topical or injectable.
• Suggest a dose, concentration, schedule, or route of administration for any individual.
• Diagnose a condition or evaluate whether a specific research finding applies to a specific person.
• Sell, source, recommend, or help locate any compound from any supplier.
• Answer requests from athletes subject to anti-doping rules about using the GLOW blend or its components, given that BPC-157 and TB-500 are prohibited in sport.

Readers seeking guidance on a health condition should consult a licensed clinician in their own jurisdiction. Responses to editorial correspondence are not guaranteed; the mailbox is monitored intermittently.